跳至主要内容
临床试验/EUCTR2022-003703-16-IT
EUCTR2022-003703-16-IT招募中1 期

The effect of phoSPHocreatine on mEdical emergency team (met) tREated patients: a randomized clinical trial protocol - SPHERE. - SPHERE

OSPEDALE SAN RAFFAELE0 个研究点目标入组 400 人开始时间: 2023年1月16日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
400

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1.Threatened airways;
  • 2. Respiratory arrest;
  • 3. Respiratory rate <5 or >36 breaths per min;
  • 4. Pulse rate <40 or >140 beats per min;
  • 5. Systolic blood pressure < 90 mm Hg;
  • 6. Sudden fall in level of consciousness;
  • 7. Fall in Glasgow coma scale of > 2 points.
  • 8. Written informed consent from the patient him-/herself or the patient's next of kin or the legal representative as requested by the ethics committee.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 200
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 200

排除标准

  • Exclusion criteria
  • 1.Age < 18 years;
  • 2. Ongoing cardiac massage;
  • 3. Current hospital admission from a care nursing facility;
  • 4. Planned discharge to a care nursing facility;
  • 5. Reasons for withdrawal of life-sustaining therapy;
  • 6. History of kidney transplantation;
  • 7. Solitary kidney (by any reason);
  • 8. Serum Creatinine > 2 mg/dl;
  • 9. Immediate need for ICU admission;
  • 10. Known allergy to PCr;
  • 11. Previous enrollment and randomization into this trial;
  • 13. Administration of PCr in the previous 30 day.
  • 14. Pregnancy

研究者

发起方
OSPEDALE SAN RAFFAELE

相似试验